Issue 4, 2023
From the journal:

Molecular Omics

Correction: Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin

Yingwei Zhang,*a   Zeyu Zhang,b   Chundi Li,a   Donge Tangb  and  Yong Dai*b  

* Corresponding authors

a Department of Nephrology, Shenzhen Longhua District Central Hospital, Shenzhen 518000, China
E-mail: 18653133290zyw@sina.com
Tel: +86-18565668800

b The Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen 518020, China
E-mail: daiyong22@163.com
Tel: +86-0755-22942780

Abstract

Correction for ‘Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin’ by Yingwei Zhang et al., Mol. Omics, 2022, 18, 643–651, https://doi.org/10.1039/D2MO00036A.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D3MO90012F
Article type
Correction
Submitted
12 Apr 2023
Accepted
12 Apr 2023
First published
18 Apr 2023
This article is Open Access
Creative Commons BY license

Mol. Omics, 2023,19, 362-362

Permissions

Request permissions

Correction: Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin

Y. Zhang, Z. Zhang, C. Li, D. Tang and Y. Dai, Mol. Omics, 2023, 19, 362 DOI: 10.1039/D3MO90012F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements